License and Development Agreements (Details) - USD ($)	1 Months Ended		12 Months Ended	60 Months Ended
	Jun. 30, 2021	Jan. 31, 2017	Dec. 31, 2021	Dec. 31, 2021
COVAXIN Preferred Stock Purchase Agreement
License agreements:
Profits generated, shared percentage			45.00%	45.00%
Collaborative Arrangement
License agreements:
Upfront payment	$ 15,000,000
Additional payment	$ 10,000,000
Schepens Eye Research Institute Research Agreement
License agreements:
Payment annual license maintenance fee			$ 16,100,000
Collaboration agreement with University of Colorado
License agreements:
Potential development and regulatory milestone payments		$ 1,500,000
Milestone payment				$ 0
Royalty payments				$ 0
Cancellation period, notice		60 days
Cancellation notice, payments period		60 days